CABALETTA BIO, INC. Depreciation
CABALETTA BIO, INC. (CABA) reported Depreciation of $708.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-13
- CABALETTA BIO, INC. depreciation for the quarter ending 2026-06-30 was $371.00K, a 20.73% decline year-over-year.
- CABALETTA BIO, INC. depreciation for the quarter ending 2026-03-31 was $337.00K, a 30.52% decline year-over-year.
- CABALETTA BIO, INC. depreciation for the quarter ending 2025-12-31 was $348.00K, a 25.64% decline year-over-year.
- CABALETTA BIO, INC. depreciation for the quarter ending 2025-09-30 was $345.00K, a 18.63% decline year-over-year.
- CABALETTA BIO, INC. depreciation for fiscal 2025 was $1.65M, a 3.80% decline from fiscal 2024.
- CABALETTA BIO, INC. depreciation for fiscal 2024 was $1.71M, a 19.99% increase from fiscal 2023.
- CABALETTA BIO, INC. depreciation for fiscal 2023 was $1.43M, a 21.05% increase from fiscal 2022.
- CABALETTA BIO, INC. depreciation for fiscal 2022 was $1.18M, a 60.71% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $371.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $708.00K 10-Q · filed 2026-08-13 | $1.06M derived: sum of 3 quarters · filed 2026-08-13 | $1.40M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $337.00K 10-Q · filed 2026-05-14 | $685.00K derived: sum of 2 quarters · filed 2026-05-14 | $1.03M derived: sum of 3 quarters · filed 2026-05-14 | $1.50M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $348.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $693.00K derived: sum of 2 quarters · filed 2026-03-23 | $1.16M derived: sum of 3 quarters · filed 2026-08-13 | $1.65M 10-K · filed 2026-03-23 |
| 2025-09-30 | $345.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $813.00K derived: sum of 2 quarters · filed 2026-08-13 | $1.30M 10-Q · filed 2025-11-10 | $1.77M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $468.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $953.00K 10-Q · filed 2026-08-13 | $1.42M derived: sum of 3 quarters · filed 2026-08-13 | $1.84M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $485.00K 10-Q · filed 2026-05-14 | $953.00K derived: sum of 2 quarters · filed 2026-05-14 | $1.38M derived: sum of 3 quarters · filed 2026-05-14 | $1.80M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $468.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $892.00K derived: sum of 2 quarters · filed 2026-03-23 | $1.32M derived: sum of 3 quarters · filed 2026-03-23 | $1.71M 10-K · filed 2026-03-23 |
| 2024-09-30 | $424.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $850.00K derived: sum of 2 quarters · filed 2025-11-10 | $1.24M 10-Q · filed 2025-11-10 | $1.58M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $426.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $819.00K 10-Q · filed 2025-08-07 | $1.16M derived: sum of 3 quarters · filed 2025-08-07 | $1.51M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $393.00K 10-Q · filed 2025-05-15 | $729.00K derived: sum of 2 quarters · filed 2025-05-15 | $1.08M derived: sum of 3 quarters · filed 2025-05-15 | $1.45M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $336.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $691.00K derived: sum of 2 quarters · filed 2025-03-31 | $1.06M derived: sum of 3 quarters · filed 2025-03-31 | $1.43M 10-K · filed 2025-03-31 |
| 2023-09-30 | $355.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $725.00K derived: sum of 2 quarters · filed 2024-11-14 | $1.09M 10-Q · filed 2024-11-14 | $1.45M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $370.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $735.00K 10-Q · filed 2024-08-08 | $1.09M derived: sum of 3 quarters · filed 2024-08-08 | $1.46M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $365.00K 10-Q · filed 2024-05-15 | $723.00K derived: sum of 2 quarters · filed 2024-05-15 | $1.09M derived: sum of 3 quarters · filed 2024-05-15 | $1.32M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $358.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $721.00K derived: sum of 2 quarters · filed 2024-03-21 | $959.00K derived: sum of 3 quarters · filed 2024-03-21 | $1.18M 10-K · filed 2024-03-21 |
| 2022-09-30 | $363.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $601.00K derived: sum of 2 quarters · filed 2023-11-09 | $820.00K 10-Q · filed 2023-11-09 | $1.05M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $238.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $457.00K 10-Q · filed 2023-08-10 | $691.00K derived: sum of 3 quarters · filed 2023-08-10 | $912.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $219.00K 10-Q · filed 2023-05-11 | $453.00K derived: sum of 2 quarters · filed 2023-05-11 | $674.00K derived: sum of 3 quarters · filed 2023-05-11 | $836.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $234.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $455.00K derived: sum of 2 quarters · filed 2023-03-16 | $617.00K derived: sum of 3 quarters · filed 2023-03-16 | $733.00K 10-K · filed 2023-03-16 |
| 2021-09-30 | $221.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $383.00K derived: sum of 2 quarters · filed 2022-11-10 | $499.00K 10-Q · filed 2022-11-10 | $609.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $162.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $278.00K 10-Q · filed 2022-08-11 | $388.00K derived: sum of 3 quarters · filed 2022-08-11 | $478.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $116.00K 10-Q · filed 2022-05-12 | $226.00K derived: sum of 2 quarters · filed 2022-05-12 | $316.00K derived: sum of 3 quarters · filed 2022-05-12 | $394.00K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $110.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $200.00K derived: sum of 2 quarters · filed 2022-03-17 | $278.00K derived: sum of 3 quarters · filed 2022-03-17 | $354.00K 10-K · filed 2022-03-17 |
| 2020-09-30 | $90.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-01 | $168.00K derived: sum of 2 quarters · filed 2021-11-01 | $244.00K 10-Q · filed 2021-11-01 | $295.00K derived: sum of 4 quarters · filed 2021-11-01 |
| 2020-06-30 | $78.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $154.00K 10-Q · filed 2021-08-05 | $205.00K derived: sum of 3 quarters · filed 2021-08-05 | $237.00K derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $76.00K 10-Q · filed 2021-05-03 | $127.00K derived: sum of 2 quarters · filed 2021-05-03 | $159.00K derived: sum of 3 quarters · filed 2021-05-03 | |
| 2019-12-31 | $51.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $83.00K derived: sum of 2 quarters · filed 2021-03-16 | $104.00K 10-K · filed 2021-03-16 | |
| 2019-09-30 | $32.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $53.00K 10-Q · filed 2020-11-10 | ||
| 2019-06-30 | $21.00K 10-Q · filed 2020-08-06 | |||
| 2018-12-31 | $0.00 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |